You are viewing the site in preview mode

Skip to main content

Table 2 Mean daily GH dose in Noonan syndrome (NS) and Turner syndrome (TS) patients over 4 years of GH treatment

From: Noonan syndrome and Turner syndrome patients respond similarly to 4 years’ growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program

  NS TS
GH dose μg/kg/day GH dose μg/kg/day
Mean ± SD (n) Mean ± SD (n)
Baseline 44.32 ± 9.63 (27) 48.24 ± 13.20 (282)
Year 1 49.33 ± 11.82 (30) 48.20 ± 12.03 (286)
Year 2 50.86 ± 12.19 (27) 47.90 ± 12.41 (287)
Year 3 50.46 ± 13.04 (28) 47.47 ± 13.57 (288)
Year 4 49.78 ± 13.56 (27) 46.50 ± 12.90 (267)